Team:Goettingen/Team/DAC

From 2013.igem.org

(Difference between revisions)
m (→edit2)
m (→Navigation:)
Line 20: Line 20:
===Navigation:===
===Navigation:===
-
<html><ul class="nav"><li><a href="/Team:Goettingen/Project">Background</a></li>
+
<html>
-
<li><a href="/Team:Goettingen/Project/OurProject">Our Project</a></li>
+
<ul class="nav"><li><a href="/Team:Goettingen/Project">Our Project</a></li>
-
                                        <ul>
+
    <ul>
<li><a href="/Team:Goettingen/Team/Reporters">Reporter Team</a></li>
<li><a href="/Team:Goettingen/Team/Reporters">Reporter Team</a></li>
                                         <li><a href="/Team:Goettingen/Team/Array">Array Team</a></li>
                                         <li><a href="/Team:Goettingen/Team/Array">Array Team</a></li>
Line 35: Line 35:
<br />
<br />
</html>
</html>
 +
===DAC Team===
===DAC Team===
<html>
<html>

Revision as of 22:26, 26 June 2013

The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria



DAC Team

Another approach of our project is the determination of the 3D structure of diadenylate cyclase (DAC) via crystallography and electron microscopy.

The advantage of the 3D structure of a protein received by crystallography is the identification of possible chemical binding sites due to computational modeling. These chemical compounds may interfere with the activity of the cyclase and could therefore be used as a potential starting point for further drug development.

Due to the fact that the diadenylate cyclase from Bacillus subtilis is difficult to crystallize, the full length protein from Listeria is going to be isolated and crystallized. Furthermore, Streptococcus and Staphylococcus will be used to obtain only the DAC domain of the protein for our analysis.

previous next

Previous Next



Retrieved from "http://2013.igem.org/Team:Goettingen/Team/DAC"